SIX Swiss Exchange-listed market expansion services provider DKSH has sold its Chinese health care business to global private equity fund manager Warburg Pincus for CHF100 million (approximately US$100 million). The transaction, which has fulfilled all necessary closing conditions and obtained the relevant regulatory approvals, includes DKSH’s pharmaceutical, consumer health and medical device businesses in China.